Quick Order Cart

Cat. No. ARG40195

DYNLT3 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

DYNLT3 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in human Burkitt??s lymphoma B cells, enabling loss-of-function analysis of the DYNLT3 dynein light chain. DYNLT3 is regulated by CDK1/PLK1 and interacts with DYNC1H1, dynactin, and adaptors like BICD2 to control retrograde transport and spindle orientation. This model supports studies of dynein motor function, intracellular trafficking, and mitotic fidelity in lymphoma, with applications in immunofluorescence, live-cell tracking, and cell cycle analysis. The EBV-positive host also facilitates exploration of viral exploitation of host dynein.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DYNLT3

    Gene Identifier

    NCBI Gene ID 6990

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

DYNLT3 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from Raji B lymphocytes, providing a heterogeneous loss-of-function model for the DYNLT3 gene. This polyclonal format avoids clonal bias and is ideal for population-based studies of dynein light chain Tctex-type function.

The Raji cell line is a suspension-adapted human Burkitt??s lymphoma line that is positive for Epstein-Barr virus (EBV) and widely used to model B-cell malignancy, EBV latency, and lymphoid signaling. Its rapid growth and well-documented oncogenic pathways, such as NF-??B and PI3K/AKT, establish a robust platform for investigating gene function in B-cell biology.

DYNLT3 encodes a light chain of cytoplasmic dynein-1, which drives retrograde transport along microtubules and organizes the mitotic spindle. The protein is regulated by CDK1 and PLK1 phosphorylation and interacts directly with dynein heavy chain DYNC1H1, light chains DYNLL1/2, and the dynactin complex. Cargo adaptors such as BICD2 and HOOK3 link DYNLT3 to specific payloads, enabling precise intracellular trafficking. Disruption of DYNLT3 therefore compromises dynein-dependent processes, including organelle positioning, chromosome segregation, and pericentriolar matrix assembly, with downstream consequences for mitotic checkpoint proteins and cargo adaptor availability.

In Raji cells, DYNLT3 knockout is highly relevant for probing the dynein motor??s role in lymphoma cell division and survival. Because EBV exploits host dynein for episomal maintenance, this model also permits examination of viral?Chost interactions that sustain latency. Loss of DYNLT3 may precipitate mitotic errors and genomic instability, offering a potent system to study mechanisms linking microtubule motor dysfunction to B-cell transformation.

These polyclonal knockout cells support diverse functional assays: Western blotting and RT-qPCR confirm target disruption, immunofluorescence reveals spindle and dynein localization defects, and live-cell tracking captures real-time trafficking and mitotic phenotypes. Cell cycle and apoptosis assays quantify proliferation and death responses, while co-immunoprecipitation maps altered dynein?Ccargo complexes. Such applications make the DYNLT3 knockout Raji model a valuable resource for dynein biology, cancer cell research, and drug discovery. For details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)